Skip to main content
logo
Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
202.50
-9.50 (-4.48%)
At close: Nov 6, 2026

Accretion Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
2,251706----
Market Cap Growth
256.83%-----
Enterprise Value
2,397783----
Last Close Price
202.5063.55----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
17.157.31----
PS Ratio
2.230.79----
PB Ratio
3.581.29----
P/TBV Ratio
3.581.29----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.370.87----
EV/EBITDA Ratio
11.845.20----
EV/EBIT Ratio
12.915.66----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.270.230.922.452.202.47
Debt / EBITDA Ratio
0.830.821.185.223.963.94
Debt / FCF Ratio
-----4.02
Net Debt / Equity Ratio
0.230.150.922.442.192.35
Net Debt / EBITDA Ratio
0.720.551.185.193.943.75
Net Debt / FCF Ratio
-1.44-0.36-6.30-0.79-9.843.82
Asset Turnover
1.381.541.710.561.54-
Inventory Turnover
2.692.682.280.853.27-
Quick Ratio
1.811.410.540.460.420.38
Current Ratio
3.702.901.441.461.051.01
Return on Equity (ROE)
23.96%27.62%65.39%31.98%3.00%-
Return on Assets (ROA)
15.85%14.85%20.67%6.14%3.96%-
Return on Invested Capital (ROIC)
17.93%22.16%32.12%11.33%8.06%8.26%
Return on Capital Employed (ROCE)
27.10%24.80%66.80%19.00%18.00%18.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
5.83%13.69%----
FCF Yield
-4.52%-32.66%----
Buyback Yield / Dilution
-20.14%-33.55%-5.47%---